+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Latin America Opioid Drugs Market 2019-2028

  • ID: 5138678
  • Report
  • August 2020
  • Region: Latin America
  • 84 pages
  • Triton Market Research

FEATURED COMPANIES

  • Acura Pharmaceuticals
  • Daiichi Sankyo
  • Hikma Pharmaceuticals plc
  • Indivior Inc
  • Johnson Johnson
  • Lannett Co Inc
MARKET OUTLOOK

The market for opioid drugs in Latin America has been projected to depict growth in terms of revenue and expand with a CAGR of 2.79% during the forecast years 2019-2028, according to a report by the publisher. Brazil, Mexico, and Rest of Latin America together form the market in this region.

In 2017, the International Narcotics Control Board (INCB) stated that, in Mexico, the percentage of legally prescribed opioid drugs is meager in comparison with the US. However, as per a 2019 research article, Mexico might transition from being a low opioid using country to a high opioid using one. Each year, around 30 million cases of people suffering from chronic pain are reported in the country.

This opens up multiple avenues for growth for players operating in the opioid drugs market. A few years back, Purdue Pharma entered the Mexican market, to tap onto its unrealized potential. This factor is helping the growth of Mexico’s opioid drugs market. However, in the coming years, the drug trafficking scenario in the country is expected to take a turn for the worse. Also, stringent guidelines with respect to opioid trade from the US and other established markets across the globe are expected to decelerate the market growth in the coming years.

COMPETITIVE OUTLOOK

The key companies profiled in the report include Johnson Johnson, Mylan NV, Purdue Pharma LP, Cipher Pharmaceuticals Inc, Sun Pharmaceutical Industries Ltd, Biodelivery Sciences International Inc, Indivior Inc, Sanofi-Aventis SA, and Lannett Co Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Acura Pharmaceuticals
  • Daiichi Sankyo
  • Hikma Pharmaceuticals plc
  • Indivior Inc
  • Johnson Johnson
  • Lannett Co Inc
1. Latin America Opioid Drugs Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Key Insights
2.2.1. Technological Advancements to Fight Against Opioid Drug Crisis
2.2.2. Different Sources of Procuring Opioids
2.3. Porter's Five Force Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Suppliers
2.3.4. Bargaining Power of Buyers
2.3.5. Threat of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Market Drivers
2.6.1. Growth in Medical Cases & Rising Prevalence of Cancer
2.6.2. Increase in the Use of Abuse-Deterrent Formulations to Restrict the Rise of Opioid Dependence
2.6.3. Demand for Palliative Therapy
2.7. Market Restraints
2.7.1. Government Rules and Regulations
2.7.2. Increased Number of Lawsuits Against the Manufacturers of Opioid Drugs
2.7.3. Usage of Opioids for Non-Medical Purposes
2.8. Market Opportunities
2.8.1. Rising Commercial Success and Market Share of Opioid Drugs
2.8.2. Growth of Investments in Research of Pharmaceutical Uses of Opioids
2.9. Market Challenges
2.9.1. Opioid Epidemic Spreading
2.9.2. Rising Death Rate Due to Opioid Overdose
2.10. Covid-19 Impact on the Opioid Drugs Market

3. Latin America Opioid Drugs Market Outlook - by Product
3.1. Buprenorphine
3.2. Fentanyl
3.3. Hydrocodone
3.4. Morphine
3.5. Oxycodone
3.6. Tramadol
3.7. Other Products

4. Latin America Opioid Drugss Market Outlook - by Application
4.1. Pain Relief
4.1.1. Cancer Pain
4.1.2. Postoperative Pain Management
4.1.3. Lower Back Pain
4.1.4. Orthopedic
4.1.5. Neuropathic
4.1.6. Fibromyalgia
4.2. Anesthesia
4.3. Cough Suppression
4.4. Diarrhea Suppression
4.5. De-Addiction

5. Latin America Opioid Drugs Market – Regional Outlook
5.1. Brazil
5.2. Mexico
5.3. Rest of Latin America

6. Competitive Landscape
6.1. Acura Pharmaceuticals
6.2. Biodelivery Sciences International Inc
6.3. Cipher Pharmaceuticals Inc
6.4. Allergan (Acquired by Abbvie)
6.5. Collegium Pharmaceutical Inc
6.6. Daiichi Sankyo
6.7. Hikma Pharmaceuticals plc
6.8. Indivior Inc
6.9. Janssen Pharmaceuticals Inc
6.10. Johnson Johnson
6.11. Lannett Co Inc
6.12. Lupin Ltd
6.13. Mylan Nv
6.14. Pfizer Inc
6.15. Purdue Pharma Lp
6.16. Sanofi-Aventis Sa
6.17. Sun Pharmaceutical Industries Ltd
6.18. Teva Pharmaceutical Industries Ltd

7. Methodology & Scope
7.1. Research Scope & Deliverables
7.2. Sources of Data
7.3. Research Methodology

List of Tables:
Table 1: Latin America Opioid Drugs Market, by Country, 2019-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Latin America Opioid Drugs Market, by Product, 2019-2028 (In $ Million)
Table 4: Latin America Opioid Drugs Market, by Application, 2019-2028 (In $ Million)
Table 5: Latin America Opioid Drugs Market, by Pain Relief, 2019-2028 (In $ Million)
Table 6: Latin America Opioid Drugs Market, by Country, 2019-2028 (In $ Million)

List of Figures:
Figure 1: Porter's Five Force Analysis
Figure 2: Market Attractiveness Index
Figure 3: Latin America Opioid Drugs Market, by Buprenorphine, 2019-2028 (In $ Million)
Figure 4: Latin America Opioid Drugs Market, by Fentanyl, 2019-2028 (In $ Million)
Figure 5: Latin America Opioid Drugs Market, by Hydrocodone, 2019-2028 (In $ Million)
Figure 6: Latin America Opioid Drugs Market, by Morphine, 2019-2028 (In $ Million)
Figure 7: Latin America Opioid Drugs Market, by Oxycodone, 2019-2028 (In $ Million)
Figure 8: Latin America Opioid Drugs Market, by Tramadol, 2019-2028 (In $ Million)
Figure 9: Latin America Opioid Drugs Market, by Other Products, 2019-2028 (In $ Million)
Figure 10: Latin America Opioid Drugs Market, by Pain Relief, 2019-2028 (In $ Million)
Figure 11: Latin America Opioid Drugs Market, by Cancer Pain, 2019-2028 (In $ Million)
Figure 12: Latin America Opioid Drugs Market, by Postoperative Pain Management, 2019-2028 (In $ Million)
Figure 13: Latin America Opioid Drugs Market, by Lower Back Pain, 2019-2028 (In $ Million)
Figure 14: Latin America Opioid Drugs Market, by Orthopedic, 2019-2028 (In $ Million)
Figure 15: Latin America Opioid Drugs Market, by Neuropathic, 2019-2028 (In $ Million)
Figure 16: Latin America Opioid Drugs Market, by Fibromyalgia, 2019-2028 (In $ Million)
Figure 17: Latin America Opioid Drugs Market, by Anesthesia, 2019-2028 (In $ Million)
Figure 18: Latin America Opioid Drugs Market, by Cough Suppression, 2019-2028 (In $ Million)
Figure 19: Latin America Opioid Drugs Market, by Diarrhea Suppression 2019-2028 (In $ Million)
Figure 20: Latin America Opioid Drugs Market, by De-Addiction, 2019-2028 (In $ Million)
Figure 21: Latin America Opioid Drugs Market; Regional Outlook 2019 & 2028 (In %)
Figure 22: Brazil Opioid Drugs Market, 2019-2028 (In $ Million)
Figure 23: Mexico Opioid Drugs Market, 2019-2028 (In $ Million)
Figure 24: Rest of Latin America Opioid Drugs Market, 2019-2028 (In $ Million)
Note: Product cover images may vary from those shown
  • Acura Pharmaceuticals
  • Biodelivery Sciences International Inc
  • Cipher Pharmaceuticals Inc
  • Allergan (Acquired by Abbvie)
  • Collegium Pharmaceutical Inc
  • Daiichi Sankyo
  • Hikma Pharmaceuticals plc
  • Indivior Inc
  • Janssen Pharmaceuticals Inc
  • Johnson Johnson
  • Lannett Co Inc
  • Lupin Ltd
  • Mylan Nv
  • Pfizer Inc
  • Purdue Pharma Lp
  • Sanofi-Aventis Sa
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll